Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
Conclusion(s): New evidence on thromboembolism in COVID-19 does not warrant a change in current guidance on thromboprophylaxis among hospitalized patients. Prospective trials of antithrombotic treatment strategies among patients with COVID-19 are urgently needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Clopidogrel | Coronavirus | COVID-19 | Databases & Libraries | Health | Plavix | SARS | Study | Thrombosis